Skip to content

The effects of counseling on improving hepatocellular carcinoma screening among patients with hepatitis B infection: a randomized controlled trial

Pilot Testing, and Evaluation of a Nurse-Led Decision Counseling Program to Improve Decision-Making and Uptake of Hepatocellular Carcinoma Screening Among Patients with Hepatitis B Virus Infection: a Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039506
Enrollment
Unknown
Registered
2020-10-30
Start date
2021-01-01
Completion date
Unknown
Last updated
2021-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatitis B

Interventions

Intervention group:Counseling
Control group:Usual care

Sponsors

The Nethersole School of Nursing, the Chinese University of Hong Kong
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with hepatitis B, aged 18-65, will be included in this study. 2. According to the guidelines, it is suitable for liver cancer screening, including cirrhosis, male age > 40, female age > 50 or family history of liver cancer. 3. According to the recommendation of the National Health Commission of the people's Republic of China, the high-risk population should be screened by liver ultrasound combined with serum alpha fetoprotein at least once every six months. Therefore, patients who did not undergo the above examinations in the past 6 months will be included in this study.

Exclusion criteria

Exclusion criteria: 1. Patients with other diseases, including hepatitis C and other chronic liver diseases, will be excluded; 2. Patients with history of liver cancer diagnosis or liver transplantation; 3. Patients with hepatic encephalopathy, mental history, gastrointestinal bleeding, etc.; 4. Patients who are not willing to participate in this study.

Design outcomes

Primary

MeasureTime frame
Hepatocellular carcinoma screening uptake rates;

Secondary

MeasureTime frame
Hepatocellular carcinoma screening knowledge;Preventive health model constructs;Decision conflict;

Countries

China

Contacts

Public ContactLI Caixia

The Nethersole School of Nursing, the Chinese University of Hong Kong

caixiali@link.cuhk.edu.hk+86 852-52610019

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026